AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $45,000 | -79.4% | 1,281 | -68.6% | 0.00% | -83.3% |
| Q2 2020 | $218,000 | +2322.2% | 4,085 | +2817.9% | 0.01% | +1100.0% |
| Q1 2019 | $9,000 | -98.3% | 140 | -97.9% | 0.00% | -96.7% |
| Q3 2018 | $517,000 | +15.7% | 6,701 | +26.4% | 0.03% | +7.1% |
| Q2 2018 | $447,000 | +3625.0% | 5,301 | +3457.7% | 0.03% | +2700.0% |
| Q1 2018 | $12,000 | -95.7% | 149 | -96.5% | 0.00% | -96.0% |
| Q3 2017 | $281,000 | +57.0% | 4,215 | +21.3% | 0.02% | +47.1% |
| Q2 2017 | $179,000 | -47.0% | 3,476 | +15.4% | 0.02% | -66.0% |
| Q4 2014 | $338,000 | – | 3,013 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |